DE69430538T2 - 2-azylalkyl-oder arylalenyl-cyclopentanheptan-und heptensäuren, derivate und therapeutische anwendung - Google Patents

2-azylalkyl-oder arylalenyl-cyclopentanheptan-und heptensäuren, derivate und therapeutische anwendung

Info

Publication number
DE69430538T2
DE69430538T2 DE69430538T DE69430538T DE69430538T2 DE 69430538 T2 DE69430538 T2 DE 69430538T2 DE 69430538 T DE69430538 T DE 69430538T DE 69430538 T DE69430538 T DE 69430538T DE 69430538 T2 DE69430538 T2 DE 69430538T2
Authority
DE
Germany
Prior art keywords
derivatives
cyclopentaneheptanic
azylalkyl
arylalenyl
heptenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69430538T
Other languages
English (en)
Other versions
DE69430538D1 (de
Inventor
W Andrews
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Sales LLC
Original Assignee
Allergan Sales LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Sales LLC filed Critical Allergan Sales LLC
Application granted granted Critical
Publication of DE69430538D1 publication Critical patent/DE69430538D1/de
Publication of DE69430538T2 publication Critical patent/DE69430538T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
DE69430538T 1993-10-28 1994-10-20 2-azylalkyl-oder arylalenyl-cyclopentanheptan-und heptensäuren, derivate und therapeutische anwendung Expired - Fee Related DE69430538T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/144,968 US5486540A (en) 1993-10-28 1993-10-28 Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalkenyl and derivatives as therapeutic agents
PCT/US1994/012017 WO1995011682A2 (en) 1993-10-28 1994-10-20 Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalkenyl and derivatives as therapeutic agents

Publications (2)

Publication Number Publication Date
DE69430538D1 DE69430538D1 (de) 2002-06-06
DE69430538T2 true DE69430538T2 (de) 2003-01-09

Family

ID=22510998

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69430538T Expired - Fee Related DE69430538T2 (de) 1993-10-28 1994-10-20 2-azylalkyl-oder arylalenyl-cyclopentanheptan-und heptensäuren, derivate und therapeutische anwendung

Country Status (9)

Country Link
US (1) US5486540A (de)
EP (1) EP0725643B1 (de)
JP (1) JPH09506081A (de)
AT (1) ATE216890T1 (de)
AU (1) AU8084494A (de)
CA (1) CA2175076A1 (de)
DE (1) DE69430538T2 (de)
ES (1) ES2176262T3 (de)
WO (1) WO1995011682A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998020881A1 (en) 1996-11-12 1998-05-22 Alcon Laboratories, Inc 15-ketal prostaglandins for the treatment of glaucoma or ocular hypertension
CA2422031C (en) * 2000-09-13 2011-11-15 Santen Pharmaceutical Co., Ltd. Ophthalmic solutions comprising difluoroprostaglandin f2 alpha
US7312247B2 (en) * 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7842727B2 (en) * 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US6495719B2 (en) 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
CA2486303C (en) * 2002-05-22 2013-04-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
WO2004046104A2 (en) * 2002-11-20 2004-06-03 Errant Gene Therapeutics, Llc Treatment of lung cells with histone deacetylase inhibitors
US20060199863A1 (en) * 2003-07-31 2006-09-07 Santen Pharmaceutical Co., Ltd. Product containing prostaglandin
US7183310B2 (en) 2004-08-10 2007-02-27 Allergan, Inc. Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
CA2587013A1 (en) * 2004-11-08 2006-05-18 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
JP2006187602A (ja) * 2004-12-09 2006-07-20 Santen Pharmaceut Co Ltd 分子内にフッ素原子を有するプロスタグランジン含有製品
RU2391983C2 (ru) * 2004-12-24 2010-06-20 Сантен Фармасьютикал Ко., Лтд Продукт, содержащий производное простагландина f2 альфа
US7618500B2 (en) * 2005-11-14 2009-11-17 Lawrence Livermore National Security, Llc Corrosion resistant amorphous metals and methods of forming corrosion resistant amorphous metals
JPWO2007097205A1 (ja) * 2006-02-02 2009-07-09 憲次 吉田 点眼剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA747723B (en) * 1974-12-11 1976-11-24 Pfizer 11-desoxy-15-substituted-omega-pentanor prostaglandins
GB1522130A (en) * 1974-11-01 1978-08-23 May & Baker Ltd Cyclopentane derivatives
JPS53135956A (en) * 1978-02-04 1978-11-28 Pfizer 111deoxyyomegaapentanol prostaglandin
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
DE3220156C2 (de) * 1982-05-28 1990-01-25 Heida Houston Tex. Thurlow Mit Metallgriffen, insbesondere Edelstahlgriffen, versehenes Koch- und Bratgeschirr mit Deckel
ATE101342T1 (de) * 1988-09-06 1994-02-15 Kabi Pharmacia Ab Prostaglandinderivate zur behandlung des gruenen stars oder einer okularen hypertension.
US5034413A (en) * 1989-07-27 1991-07-23 Allergan, Inc. Intraocular pressure reducing 9,11-diacyl prostaglandins
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5468778A (en) * 1992-09-24 1995-11-21 Allergan, Inc. Method of lowering intraocular pressure by administering a pharmaceutical composition containing 7-(5-substituted cyclopentyl) and 7-(5-substituted-cyclopentenyl) 5-heptenoic acids and derivatives

Also Published As

Publication number Publication date
CA2175076A1 (en) 1995-05-04
ATE216890T1 (de) 2002-05-15
ES2176262T3 (es) 2002-12-01
JPH09506081A (ja) 1997-06-17
WO1995011682A2 (en) 1995-05-04
US5486540A (en) 1996-01-23
EP0725643A1 (de) 1996-08-14
WO1995011682A3 (en) 1995-05-18
DE69430538D1 (de) 2002-06-06
AU8084494A (en) 1995-05-22
EP0725643B1 (de) 2002-05-02

Similar Documents

Publication Publication Date Title
DE69430538T2 (de) 2-azylalkyl-oder arylalenyl-cyclopentanheptan-und heptensäuren, derivate und therapeutische anwendung
EP1225168B8 (de) Prostaglandin-F-2-alpha Derivat zur Behandlung von Glaukom und Augenhochdruck
DK1039895T3 (da) Anvendelse af 3-benzoylphenyleddikesyrer, estere eller amider til behandling af GLC1A-glaukom
LU92058I2 (fr) Travoprost et ses sels pharmaceutiquement acceptables (TRAVATAN®)
FI954130A (fi) Heterosykliset yhdisteet ja niiden valmistus ja käyttö
IE940525L (en) Known and selected novel arylmethylenyl derivatives of¹thiazolidinones, imidazolidinones and oxazolidinones useful¹as antiallergy agents and antiinflammatory agents
ES2191208T3 (es) Oxiimino-pregnano-carbolactonas.
TR199701490A2 (xx) 3-Hidroksipiridin-2-karbonasitamidester ve bunlar�n imalat�.
EP0824910A3 (de) Verwendung eines Krill-Enzyms zur Behandlung von Zahnbelag
ES2162110T3 (es) Derivados de la quinolina antimalaria.
PT736029E (pt) Sulfamatos de pseudofructopiranose anticonvulsivos
GB2380939B (en) Treatment or prevention of auto-immune diseases
EA200000242A1 (ru) Применение фанхинона для лечения болезни альцгеймера
NO982229D0 (no) Svovelholdige di-tert-butylfenol-forbindelser anvendbare som antiinflammatoriske midler
PE60096A1 (es) Inhibidor de la escualeno sintetasa
RU95113437A (ru) (h±)-сложный этиловый эфир транс-2-диметиламино-1-фенил-3-циклогексентранс-1-карбоновой кислоты в виде первичного ортофосфата и твердая фармацевтическая композиция с обезболивающей активностью
EA199600087A1 (ru) Композиция, обладающая антивирусной активностью, способ ее получения и фармацевтическая композиция на ее основе
BR9507135A (pt) Composto uso do mesmo processo de preparação do mesmo composição farmacêutica e composição cosmética
WO1996021670A3 (en) Antifungal fusacandins
KR950032113A (ko) 프로스타글란딘 에프 에스테르
CA2038416A1 (en) Ascorbic acid derivatives
ES2096559T3 (es) Interferon gamma humano, procedimiento para la preparacion de dicho interferon gamma humano, y su uso.
EP0310969A3 (de) Pyridobenzothiazinderivate mit bakterizider Wirkung und hoher Biobenutzbarkeit
CA2201779A1 (en) The manufacture of levobupivacaine and analogues thereof from l-lysine

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee